Figure 5From: Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein CDDAVP reduction of ADAMTS13 is mediated via the V2-receptor signaling. Using a V2-selective receptor antagonist (tolvaptan, 50 nmol/L) prevented DDAVP-induced reduction of ADAMTS13 transcripts in endothelial cells after 24 h of incubation.Back to article page